About 5,283 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  1,670 results

Hidradenitis suppurativa should be recognised as a weight-related comorbidity in NICE g...
Clinical and Experimental Dermatology; Hussain K, Khalil N et. al.

Mar 28th, 2023 - Hidradenitis suppurativa should be recognised as a weight-related comorbidity in NICE guidelines on managing obesity.|2023|Hussain K,Khalil N,Patel NP,|

Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link bet...
Archives of Dermatological Research; Agamia NF, Sorror OA et. al.

Mar 25th, 2023 - Hypoxia-inducible factor-1α (HIF-1α) is the master transcription factor of glycolysis, Th17 cell differentiation and suppression of regulatory T cells. In the skin and serum of patients with psoriasis vulgaris, increased expression of HIF-1α has b...

Expert consensus on priority research gaps in dietary and lifestyle factors in hidraden...
Archives of Dermatological Research; Yamanaka-Takaichi M, Revankar R et. al.

Mar 24th, 2023 - Hidradenitis suppurativa (HS) is a debilitating systemic inflammatory disease with limited treatment options. Although management through dietary and lifestyle changes is a primary interest of the HS patient community, there is lack of consensus r...

The thoracodorsal artery perforator (TDAP) flap for the treatment of hidradenitis suppu...
Plastic and Reconstructive Surgery; La Padula S, Pensato R et. al.

Mar 23rd, 2023 - Hidradenitis suppurativa (HS) is a common chronical condition. It is often resistant to conservative treatment and requires a wide and aggressive surgical approach to avoid recurrence. A prospective study was compared comparing the outcomes of tho...

Racial and Ethnic Health Disparities in Dermatology.
Dermatologic Clinics; Brown SG, Cobb CBC et. al.

Mar 19th, 2023 - Health disparities are differences in health or disease incidence, prevalence, severity, or disease burden that are experienced by disadvantaged populations. Their root causes are attributed in large part to socially determined factors, including ...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  151 results

A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions

Mar 10th, 2023 - The goal of enrollment will be up to 10 subjects, which is based on feasibility and access to suitable patients during the enrollment period. Subjects will be consented prior to any study procedure being performed. Surgical planning, approach and ...

Efficacy of Laser Hair Removal Therapy in HS

Mar 9th, 2023 - Hidradenitis suppurativa (HS) is a chronic, recurrent and debilitating inflammatory skin disorder, characterized by painful inflamed nodules, abscesses and tunnels in the skin folds such as the axilla, inguinal region and gluteal area. The primary...

Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients

Mar 7th, 2023 - Single center, open-label, baseline-controlled study evaluating the use of a Sciton fractionated ablative laser in the treatment of Hidradenitis Suppurativa (HS) scarring. The device is FDA approved for the treatment of scarring in all skin types....

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor...

Mar 7th, 2023 - Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. Despit...

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

Mar 7th, 2023 - This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants who completed treatment can join this study. The purpose of this study is to find out how safe spes...

see more →

News  274 results

Psychosocial Burden of Hidradenitis Suppurativa
Jennifer Hsiao, MD

Feb 22nd, 2023 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that typically presents as inflamed nodules, abscesses, and sinus tracts in the apocrine gland–bearing regions. Chronic pain, fatigue, and social isolation put patients with HS a.

Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
Doug Brunk

Feb 14th, 2023 - When administered subcutaneously every 2 weeks, secukinumab was effective at improving signs and symptoms of moderate to severe hidradenitis suppurativa (HS) in adults up to 52 weeks, results from two pivotal phase 3 clinical trials showed. The fi.

Scalp ridges
MDedge Family Medicine;

Jan 31st, 2023 - The gyrate or cerebriform pattern of inflammatory, often pus-filled, subcutaneous tracts of the scalp pointed to a diagnosis of dissecting cellulitis. This patient did not have the fluctuant tracts frequently seen in more active disease but did ha.

Phase III Trials Back Bimekizumab for Spondyloarthritis

Jan 17th, 2023 - Bimekizumab, an investigational biologic drug targeting interleukin (IL)-17A/F, appeared highly effective in patients with axial spondyloarthritis (axSpA), researchers said. With nearly 600 patients enrolled in two parallel phase III trials, 45% a...

A practical guide to hidradenitis suppurativa
MDedge Family Medicine; Cristina Marti-Amarista, MD, Mayur Rali, MD

Dec 12th, 2022 - Hidradenitis suppurativa (HS), also known as acne inversa or Verneuil disease, is a chronic, recurrent, inflammatory occlusive disease affecting the terminal follicular epithelium in apocrine gland–bearing skin areas. 1 HS manifests as painful nodu.

see more →

Patient Education  15 results see all →